NDC 0641-6006-01 - Atropine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6006
- Requested NDC
- 0641-6006-01
- Package NDCs from labels
- 0641-6006-01, 0641-6006-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atropine Sulfate Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Atropine Sulfate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Atropine Sulfate - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Atropine Sulfate Injection, USP FOR IM, IV, OR SC USE Rx Only | Henry Schein, Inc. | 2022-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
| ATROPINE SULFATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2020-09-04 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6006-01 | Atropine Sulfate | 20 mL in 1 VIAL | INJECTION | 20 | 4 | |
| 0641-6006-10 | Atropine Sulfate | 10 in 1 CARTON | INJECTION | 10 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6006-01 | ML - Milliliter | 0641-6006 | 0dd1cebf-afb5-463c-8066-2ae1248537db | 1 | 2012-07-24 |
| 0641-6006-10 | ML - Milliliter | 0641-6006 | 50fad021-aa7f-43ab-b295-6c10da590ef3 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ATROPINE SULFATE | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| Atropine Sulfate | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION [GENERAL INJECTABLES & VACCINES, INC] | 1 | |
| ATROPINE | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| Atropine | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION [GENERAL INJECTABLES & VACCINES, INC] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ATROPINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA ALLERGY | ADRENALINUM - ALLIUM CEPA - AMMONIUM CARBONICUM - APIS MELLIFICA - ARGENTUM NITRICUM - ARSENICUM ALBUM - CUPRUM ACETICUM - GALPHIMIA GLAUCA - GLANDULA SUPRARENALIS SUIS - HISTAMINUM HYDROCHLORICUM - LUFFA OPERCULATA - MATRICARIA CHAMOMILLA - MUCOSA NASALIS SUIS - NATRUM MURIATICUM - SABADILLA - SCILLA MARITIMA - | Guna spa | ae6bd80d-2c70-1a3f-e053-2a95a90a2652 | 2020-10-23 | Warnings | 451W47IQ8X |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | 2020-10-20 | Warnings, Adverse reactions | 451W47IQ8X |
| ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 77935b57-fcf6-c88a-e053-2a91aa0a0a80 | 2020-09-04 | Warnings, Adverse reactions | 51662-1311-3 51662-1311-1 51662-1311-2 51662-1311 1190776 ae808675-c055-7f6c-e053-2995a90a5b49 77935b57-fcf6-c88a-e053-2a91aa0a0a80 03J5ZE7KA5 |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | ac0fd44a-3f39-8d7e-e053-2995a90afeec | 2020-08-04 | Warnings, Adverse reactions | 451W47IQ8X |
| Bach Original Flower Remedies | WATER | Nelson Bach USA Limited | 09c76050-42c5-4403-865c-a1f6f668d9c0 | 2020-06-15 | Warnings | 059QF0KO0R |
| Cardioplegic | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM CHLORIDE | Baxter Healthcare Corporation | 1fd50ce5-2799-4c26-81da-02cf0578dd9e | 2020-06-11 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a62b71db-8ba2-6f6b-e053-2a95a90a29d1 | 2020-05-21 | Warnings, Adverse reactions | 451W47IQ8X |
| LACTATED RINGERS AND DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | HF Acquisition Co LLC, DBA HealthFirst | a62cf623-9b8a-37e0-e053-2995a90add5b | 2020-05-21 | Warnings, Adverse reactions | 451W47IQ8X |
| Hay Fever | APIS MELLIFICA, ECHINACEA, HYDRASTIS CANADENSIS, TARAXACUM OFFICINALE, ACONITUM NAPELLUS, ALFALFA, ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, AMMONIUM CARBONICUM, ARALIA RACEMOSA, ARSENICUM ALBUM, ARTEMISIA VULGARIS, ARUNDO MAURITANICA, BELLIS PERENNIS, BERBERIS VULGARIS, BRYONIA, CALLUNA VULGARIS, FLOS, CHELIDONIUM MAJUS, CHENOPODIUM ANTHELMINTICUM, CISTUS CANADENSIS, DROSERA, DULCAMARA, EUPATORIUM PERFOLIATUM, EUPHRASIA OFFICINALIS, FAGUS SYLVATICA, FRAXINUS AMERICANA, GELSEMIUM SEMPERVIRENS | Newton Laboratories, Inc. | a6045b91-d361-2731-e053-2a95a90a9772 | 2020-05-18 | Warnings | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2020-05-14 | Warnings, Adverse reactions | 451W47IQ8X |
| DEXTROSE AND SODIUM CHLORIDE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE | Fresenius Kabi USA, LLC | b825c9c4-f2fb-4a4a-9d8c-fb020ad07e93 | 2020-04-30 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a2b8220f-e33a-51c3-e053-2995a90a0734 | 2020-04-07 | Warnings, Adverse reactions | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a2bba76a-08ce-6902-e053-2995a90ab9c9 | 2020-04-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Atropine Sulfate | ATROPINE SULFATE | Bausch & Lomb Incorporated | c0a56d60-0914-42b1-af59-c56afe93d18c | 2020-04-02 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Proficient Rx LP | c832ef16-a06e-4e47-9df3-ab33bdfa6e56 | 2020-03-01 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | fbc01464-8885-4075-af41-911ffec5ae92 | 2020-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Phenohytro | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Winder Laboratories, LLC | 27c8baac-f8ce-46d8-8a0f-ff769dd408d9 | 2019-12-27 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Phenohytro | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, AND SCOPOLAMINE HYDROBROMIDE | Winder Laboratories LLC | 29be31ef-108e-4b45-9ecc-b6d671da2826 | 2019-10-04 | Warnings, Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.